Become a Member
Opinion

Finally it arrived: the year Bibi lost

Netanyahu's vaccine plan succeeded, but even that couldn't keep him in power

September 2, 2021 17:09
100251054
LONDON, ENGLAND - JUNE 06: Israeli Prime Minister Benjamin Netanyahu arrives to meet British Prime Minister Theresa May on Downing Street ahead of a meeting at Number 10 on June 6, 2018 in London, England. Mr Netanyahu is currently on a European tour in an effort to rally support from leaders to scrap the existing Iran nuclear deal. (Photo by Jack Taylor/Getty Images)
7 min read

Two men influenced events in Israel more than anyone else during the last year. One Jewish, but not Israeli; the other Israeli but not Jewish; neither of them were known to the overwhelming majority of Israelis a year ago.

Albert Bourla, Greek-American CEO of pharmaceutical giant Pfizer, emerged early in the year as the winner in the greatest scientific challenge of the age. Together with biotechnology research company BioNTech, Pfizer led the race to develop a vaccine for Covid-19, and had taken the calculated risk to go ahead with production, even before US and European medicine regulation agencies had approved it for use. His gamble not only created massive profits for Pfizer, it made his personal phone number one of the most sought-after among world leaders, anxious to secure early deliveries.

No leader was more “obsessive”, according to Mr Bourla, than Benjamin Netanyahu, who had called him more than 30 times, finally reaching an agreement to make Israel where Pfizer would conduct early field trials of the BioNTech vaccine.

So many hyperbolic headlines have been written on Israel’s “world-beating” vaccine roll-out that it’s worth going back in time and unpacking what actually lead to the groundbreaking deal with Pfizer.

To get more from opinion, click here to sign up for our free Editor's Picks newsletter.